China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Dual-Targeted Combined Intervention in High-Risk HBV-Related Hepatocellular Carcinoma: An Observational Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133999
Registration Time: 2026/10/10
Type: Observational study
Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341799
Published by HT Digital Content Services with permission from Health Daily Digest....